Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence

This study has been withdrawn prior to enrollment.
(Recruitment not progressing as planned.)
Sponsor:
Information provided by (Responsible Party):
Elizabeth Ralevski, Yale University
ClinicalTrials.gov Identifier:
NCT00463775
First received: April 18, 2007
Last updated: January 26, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)